These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy. Ma J; Ma P; Zhao C; Xue X; Han H; Liu C; Tao H; Xiu W; Cai J; Zhang M Oncotarget; 2016 May; 7(20):29480-91. PubMed ID: 27121051 [TBL] [Abstract][Full Text] [Related]
65. B7-H3 role in the immune landscape of cancer. Castellanos JR; Purvis IJ; Labak CM; Guda MR; Tsung AJ; Velpula KK; Asuthkar S Am J Clin Exp Immunol; 2017; 6(4):66-75. PubMed ID: 28695059 [TBL] [Abstract][Full Text] [Related]
66. Extracellular vesicle-based checkpoint regulation and immune state in cancer. Mortezaee K; Majidpoor J Med Oncol; 2022 Sep; 39(12):225. PubMed ID: 36175741 [TBL] [Abstract][Full Text] [Related]
67. Genetic and clinical characterization of B7-H3 (CD276) expression and epigenetic regulation in diffuse brain glioma. Wang Z; Wang Z; Zhang C; Liu X; Li G; Liu S; Sun L; Liang J; Hu H; Liu Y; Zhang W; Jiang T Cancer Sci; 2018 Sep; 109(9):2697-2705. PubMed ID: 30027617 [TBL] [Abstract][Full Text] [Related]
68. The Concordant Disruption of B7/CD28 Immune Regulators Predicts the Prognosis of Oral Carcinomas. Chang SR; Chou CH; Liu CJ; Lin YC; Tu HF; Chang KW; Lin SC Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983005 [TBL] [Abstract][Full Text] [Related]
69. A novel anti-B7-H3 chimeric antigen receptor from a single-chain antibody library for immunotherapy of solid cancers. Birley K; Leboreiro-Babe C; Rota EM; Buschhaus M; Gavriil A; Vitali A; Alonso-Ferrero M; Hopwood L; Parienti L; Ferry G; Flutter B; Himoudi N; Chester K; Anderson J Mol Ther Oncolytics; 2022 Sep; 26():429-443. PubMed ID: 36159778 [TBL] [Abstract][Full Text] [Related]
70. B7-H3 confers resistance to Vγ9Vδ2 T cell-mediated cytotoxicity in human colon cancer cells via the STAT3/ULBP2 axis. Lu H; Ma Y; Wang M; Shen J; Wu H; Li J; Gao N; Gu Y; Zhang X; Zhang G; Shi T; Chen W Cancer Immunol Immunother; 2021 May; 70(5):1213-1226. PubMed ID: 33119798 [TBL] [Abstract][Full Text] [Related]
71. New B7 Family Checkpoints in Human Cancers. Ni L; Dong C Mol Cancer Ther; 2017 Jul; 16(7):1203-1211. PubMed ID: 28679835 [TBL] [Abstract][Full Text] [Related]
72. Alternative immune checkpoints in immunoregulatory profile of cancer stem cells. Mortezaee K; Majidpoor J Heliyon; 2023 Dec; 9(12):e23171. PubMed ID: 38144305 [TBL] [Abstract][Full Text] [Related]
73. B7-H3 was highly expressed in human primary hepatocellular carcinoma and promoted tumor progression. Wang F; Wang G; Liu T; Yu G; Zhang G; Luan X Cancer Invest; 2014 Jul; 32(6):262-71. PubMed ID: 24787022 [TBL] [Abstract][Full Text] [Related]
74. Tandem CAR-T cells targeting CD70 and B7-H3 exhibit potent preclinical activity against multiple solid tumors. Yang M; Tang X; Zhang Z; Gu L; Wei H; Zhao S; Zhong K; Mu M; Huang C; Jiang C; Xu J; Guo G; Zhou L; Tong A Theranostics; 2020; 10(17):7622-7634. PubMed ID: 32685008 [No Abstract] [Full Text] [Related]
75. Expression and clinical significance of VISTA, B7-H3, and PD-L1 in glioma. Wang LC; Wang YL; He B; Zheng YJ; Yu HC; Liu ZY; Fan RR; Zan X; Liang RC; Wu ZP; Tang X; Wang GQ; Xu JG; Zhou LX Clin Immunol; 2022 Dec; 245():109178. PubMed ID: 36368642 [TBL] [Abstract][Full Text] [Related]
76. New Emerging Targets in Cancer Immunotherapy: The Role of B7-H3. Koumprentziotis IA; Theocharopoulos C; Foteinou D; Angeli E; Anastasopoulou A; Gogas H; Ziogas DC Vaccines (Basel); 2024 Jan; 12(1):. PubMed ID: 38250867 [TBL] [Abstract][Full Text] [Related]
77. Multiple Immune-Suppressive Mechanisms in Fibrolamellar Carcinoma. Kim AK; Gani F; Layman AJ; Besharati S; Zhu Q; Succaria F; Engle EL; Bhaijee F; Goggins MB; Llosa NJ; Pawlik TM; Yarchoan M; Jaffee EM; Simons HC; Taube JM; Anders RA Cancer Immunol Res; 2019 May; 7(5):805-812. PubMed ID: 30902819 [TBL] [Abstract][Full Text] [Related]
78. A high-content screen of FDA approved drugs to enhance CAR T cell function: ingenol-3-angelate improves B7-H3-CAR T cell activity by upregulating B7-H3 on the target cell surface via PKCα activation. Lee HW; O'Reilly C; Beckett AN; Currier DG; Chen T; DeRenzo C J Exp Clin Cancer Res; 2024 Apr; 43(1):97. PubMed ID: 38561833 [TBL] [Abstract][Full Text] [Related]
79. B7 homolog 3 in pancreatic cancer. Perovic D; Dusanovic Pjevic M; Perovic V; Grk M; Rasic M; Milickovic M; Mijovic T; Rasic P World J Gastroenterol; 2024 Aug; 30(31):3654-3667. PubMed ID: 39193002 [TBL] [Abstract][Full Text] [Related]
80. Immune checkpoint B7-H3 protein expression is associated with poor outcome and androgen receptor status in prostate cancer. Nunes-Xavier CE; Kildal W; Kleppe A; Danielsen HE; Waehre H; Llarena R; Maelandsmo GM; Fodstad Ø; Pulido R; López JI Prostate; 2021 Sep; 81(12):838-848. PubMed ID: 34125445 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]